经膈下动脉介入治疗肝脏肿瘤的并发症及处理  

COMPLICATIONS OF TRANS-INFERIOR-PHRENIC-ARTERY INTERVENTION THERAPY FOR LIVER CANCER AND THEIR MANAGEMENT

作　　者：孙成建[1] 于春鹏[1] 江世东[2] 

机构地区：[1]青岛大学医学院附属医院介入放射科,山东青岛266003 [2]即墨市人民医院放射科

出　　处：《青岛大学医学院学报》2011年第2期161-162,165,共3页Acta Academiae Medicinae Qingdao Universitatis

摘　　要：目的探讨经膈下动脉介入治疗肝脏肿瘤的并发症及处理措施。方法对58例经血管造影确认有膈下动脉参与肝脏肿瘤供血的病人进行了75例次经导管动脉内化疗栓塞术,其中肝细胞癌47例,胆管细胞癌8例,肝转移瘤3例。结果术后综合并发症发生率为22.4%,其中发生顽固性呃逆1例,肝肾综合征1例,碘油脑栓塞1例,膈下脓肿1例,膈肌麻痹1例。结论经膈下动脉介入治疗肝脏肿瘤所出现的并发症多无严重后果,发生的原因可能为多种因素综合作用的结果。异常交通支及动-静脉瘘是导致并发症的高危因素,应引起介入治疗医师的足够重视。Objective To investigate the complications of trans-inferior-phrenic-artery（TIPA） intervention therapy for liver cancer and its management. Methods Fifty-eight patients who were confirmed by angiography that inferior phrenic arteries were involved in blood supply of the liver tumors were treated by transcatheter arterial chemoembolization（TACE）,of which,hepatic cellular cancer（HCC） 47 cases,cholangiocellular carcinoma（CC） eight cases and liver metastatic tumor three cases. Results Post-operative complication rate was 22.4%,including intractable hiccup,hepatorenal syndrome,cerebral embolism bylipiodol,subphrenic abscess,and phrenoparalysis,one case respectively. Conclusion Most complications of TIPA intervention therapy for liver tumor are not severe,which are caused by multiple factors.Abnormal communicating branches and arteriovenous shunt are risk factors contributing the complications,which should be thought highly by doctors concerned.

关 键 词：肝脏肿瘤 膈下动脉 化学栓塞 治疗性 手术后并发症 

分 类 号：R735.7[医药卫生—肿瘤] R815[医药卫生—临床医学]